Paul Tudor Jones's PVLA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 7,906 shares of Palvella Therapeutics, Inc. (PVLA) worth $1.21 M, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in PVLA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Palvella Therapeutics (PVLA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Palvella Therapeutics (PVLA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +7,906 | New Buy | 7,906 | $152.82 |
Paul Tudor Jones's Palvella Therapeutics Investment FAQs
Paul Tudor Jones first purchased Palvella Therapeutics, Inc. (PVLA) in Q2 2026, acquiring 7,906 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Palvella Therapeutics, Inc. (PVLA) for 1 quarters since Q2 2026.
Paul Tudor Jones's largest addition to Palvella Therapeutics, Inc. (PVLA) was in Q2 2026, adding 7,906 shares worth $1.21 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 7,906 shares of Palvella Therapeutics, Inc. (PVLA), valued at approximately $1.21 M.
As of the Q2 2026 filing, Palvella Therapeutics, Inc. (PVLA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Palvella Therapeutics, Inc. (PVLA) was 7,906 shares, as reported at the end of Q2 2026.